Case number 2021-1059
Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 17, 2021 | 18 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [17] filed by Appellants Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC.; issuing mandate. Service as of this date by the Clerk of Court. [756654] [EKD] [Entered: 02/17/2021 08:47 AM] (2) |
| Feb 16, 2021 | 17 | MOTION of Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 02/16/2021 by email. [756339] [21-1059] [Paul Skiermont] [Entered: 02/16/2021 02:56 PM] (7) |
| Jan 12, 2021 | 16 | ORDER granting motion to set briefing schedule [15] to the extent that the appellants' opening brief is due no later than February 16, 2021. The appellees' response brief is due no later than March 29, 2021. The deadline under Federal Circuit Rule 33(a)(1) is extended to April 5, 2021. The appellants' reply brief is due no later than April 19, 2021. The joint appendix is due no later than April 26, 2021, and the deadline under Federal Circuit Rule 33(a)(2) is extended to April 26, 2021. Service as of this date by the Clerk of Court. [748862] [LMS] [Entered: 01/12/2021 04:22 PM] (2) |
| Jan 8, 2021 | 15 | MOTION of Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC to set briefing schedule. Service: 01/08/2021 by email. [748168] [21-1059] [Sarah Spires] [Entered: 01/08/2021 03:56 PM] (9) |
| Nov 25, 2020 | 14 | ORDER granting motion [13]. (See order for briefing schedule). Service as of this date by the Clerk of Court. [738441] [NL] [Entered: 11/25/2020 01:18 PM] (2) |
| Nov 23, 2020 | 13 | MOTION of Appellants Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC to set briefing schedule. Service: 11/23/2020 by email. [737565] [21-1059] [Sarah Spires] [Entered: 11/23/2020 10:49 AM] (10) |
| Nov 10, 2020 | 12 | Entry of appearance for John B. Bourke as counsel for Appellees Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/10/2020 by email. [734728] [21-1059] [John Bourke] [Entered: 11/10/2020 11:47 AM] (1) |
| Nov 6, 2020 | 11 | Corrected Entry of appearance for Mary W. Bourke; Dana K. Severance; Joshua P. Davis; John W. Cox; Daniel M. Attaway; Kenneth Mueller as counsel for Appellees Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/06/2020 by email. [734156] [21-1059]--[Edited 11/10/2020 by EKD to correct docket text] [Mary Bourke] [Entered: 11/06/2020 10:42 AM] (2) |
| Nov 5, 2020 | 10 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Ferring B.V., Ferring International Center SA, and Ferring Pharmaceuticals Inc., Entry of Appearance [3], is not in compliance with the rules of this court (see attached). Compliant document is due on 11/13/2020. Service as of this date by the Clerk of Court. [733774] [EKD] [Entered: 11/05/2020 09:10 AM] (1) |
| Nov 4, 2020 | 9 | Entry of appearance for Sheetal S. Patel as counsel for Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC. Service: 11/04/2020 by email. [733682] [21-1059] [Sheetal Patel] [Entered: 11/04/2020 03:59 PM] (1) |
| Nov 2, 2020 | 3 | Entry of appearance for Mary W. Bourke; Dana K. Severance; Joshua P. Davis; John W. Cox; Daniel M. Attaway; Kenneth Mueller; John B. Bourke as counsel for Appellees Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc. Service: 11/02/2020 by email. [733113] [21-1059] This document is non-compliant. See Doc No. [10] [Mary Bourke] [Entered: 11/02/2020 08:05 PM] (2) |
| Nov 2, 2020 | 4 | Certificate of Interest for Appellees Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/02/2020 by email. [733115] [21-1059] [Mary Bourke] [Entered: 11/02/2020 08:06 PM] (3) |
| Nov 2, 2020 | 5 | Docketing Statement for the Appellees Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/02/2020 by email. [733117] [21-1059] [Mary Bourke] [Entered: 11/02/2020 08:08 PM] (2) |
| Nov 2, 2020 | 6 | Entry of appearance for Paul J. Skiermont; Sarah E. Spires; Jaime K. Olin as counsel for Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC. Service: 11/02/2020 by email. [733124] [21-1059] [Paul Skiermont] [Entered: 11/02/2020 08:42 PM] (2) |
| Nov 2, 2020 | 7 | Docketing Statement for the Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC. Service: 11/02/2020 by email. [733126] [21-1059] [Paul Skiermont] [Entered: 11/02/2020 08:44 PM] (2) |
| Nov 2, 2020 | 8 | Certificate of Interest for Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC. Service: 11/02/2020 by email. [733127] [21-1059] [Paul Skiermont] [Entered: 11/02/2020 08:45 PM] (3) |
| Oct 30, 2020 | 2 | Transcript Purchase Order Form for the Appellants Reprise Biopharmaceutics, LLC and Serenity Pharmaceuticals, LLC indicating that a transcript is already on file. Service: 10/30/2020 by email. [732562] [21-1059] [Paul Skiermont] [Entered: 10/30/2020 12:50 PM] (1) |
| Oct 19, 2020 | 1 | Appeal docketed. Received: 10/16/2020. [729707]Entry of Appearance is due on 11/02/2020. Certificate of Interest is due on 11/02/2020. Docketing Statement is due on 11/02/2020. Appellants' brief is due on 12/18/2020. [EKD] [Entered: 10/19/2020 10:45 AM] (277) |
